{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:22:25Z","timestamp":1794666145207,"version":"4.9.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Guanfacine, an enteral \u03b1\n                      <jats:sub>2<\/jats:sub>\n                      -adrenergic and imidazoline receptor agonist, has occasionally been described in critical care as an adjunctive agent for the management of delirium and suspected dexmedetomidine withdrawal. However, its pharmacokinetic behavior during venovenous extracorporeal membrane oxygenation (VV ECMO) combined with continuous venovenous hemofiltration (CVVH) has not been defined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A 64-year-old man with severe COVID-19 pneumonia developed refractory hypoxemia, requiring VV ECMO and CVVH for multiorgan support. Enteral guanfacine 7 mg\/d was initiated on day 14 to transition from dexmedetomidine sedation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Steady-state trough plasma and ultrafiltrate guanfacine concentrations of 3.2 and 0.5 ng\/mL, respectively, were obtained on day 24, yielding a sieving coefficient of 0.16 and convective clearance of 0.267 mL\/min. ECMO adsorption was negligible based on expected pharmacokinetic concentrations. The patient was decannulated from ECMO on day 30, and guanfacine was successfully tapered over 7 days without withdrawal symptoms occurring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In this patient, high-dose guanfacine achieved predicted plasma concentrations during concurrent VV ECMO and CVVH, with minimal extracorporeal clearance or circuit sequestration. These findings suggest that standard dosing is appropriate in similar patients and support the use of guanfacine as a viable transition agent during dexmedetomidine weaning. Prospective pharmacokinetic studies in ECMO-supported patients are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001447","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T05:01:21Z","timestamp":1770354081000},"page":"421-423","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic Drug Monitoring of Guanfacine for Sedation in a Patient on Extracorporeal Membrane Oxygenation and Continuous Venovenous Hemofiltration: Grand Round\/A Case Study"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9349-0261","authenticated-orcid":false,"given":"David K.","family":"Carroll","sequence":"first","affiliation":[{"name":"Detroit Medical Center, Detroit, Michigan;"},{"name":"Department of Emergency Medicine, Wayne State University School of Medicine, Detroit, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"King","sequence":"additional","affiliation":[{"name":"Detroit Medical Center, Detroit, Michigan;"},{"name":"Department of Emergency Medicine, Wayne State University School of Medicine, Detroit, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandtly","family":"Yakey","sequence":"additional","affiliation":[{"name":"Detroit Medical Center, Detroit, Michigan;"},{"name":"Department of Emergency Medicine, Wayne State University School of Medicine, Detroit, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aria","family":"Darling","sequence":"additional","affiliation":[{"name":"Detroit Medical Center, Detroit, Michigan;"},{"name":"Department of Emergency Medicine, Wayne State University School of Medicine, Detroit, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon N.","family":"Carroll","sequence":"additional","affiliation":[{"name":"City University of New York, New York, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Isaacson","sequence":"additional","affiliation":[{"name":"Detroit Medical Center, Detroit, Michigan;"},{"name":"Department of Surgery, Wayne State University School of Medicine, Detroit, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"R1-20261114","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/MAT.0000000000001758","article-title":"Analgosedation in critically ill adults receiving extracorporeal membrane oxygenation support","volume":"68","author":"Crow","year":"2022","journal-title":"ASAIO J"},{"key":"R2-20261114","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2344\/0003-3006-62.1.31","article-title":"Alpha-2 adrenergic receptor agonists: a review of current clinical applications","volume":"62","author":"Giovannitti","year":"2015","journal-title":"Anesth Prog"},{"key":"R3-20261114","first-page":"e0785","article-title":"Effect of enteral guanfacine on dexmedetomidine use in the ICU","volume":"4","author":"Fetters","year":"2022","journal-title":"Crit Care Explor"},{"key":"R4-20261114","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/08971900241263171","article-title":"Alpha2 agonist use in critically ill adults: a focus on sedation and withdrawal prevention","volume":"38","author":"Schuler","year":"2025","journal-title":"J Pharm Pract"},{"key":"R5-20261114","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40261-025-01434-x","article-title":"Guanfacine use in the ICU for management of sedation weaning","volume":"45","author":"Lee","year":"2025","journal-title":"Clin Drug Investig"},{"key":"R6-20261114","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2147\/NDT.S1711","article-title":"Once-daily treatment of ADHD with guanfacine: patient implications","volume":"4","author":"Strange","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R7-20261114","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/JCP.0000000000001004","article-title":"Pharmacokinetics and pharmacodynamics of immediate-release versus extended-release guanfacine in adult daily smokers","volume":"39","author":"Verplaetse","year":"2019","journal-title":"J Clin Psychopharmacol"},{"key":"R8-20261114","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.clinthera.2007.04.016","article-title":"A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-2-and 4-mg tablets in healthy adults","volume":"29","author":"Swearingen","year":"2007","journal-title":"Clin Ther"},{"key":"R9-20261114","first-page":"535","article-title":"A HPLC-MS method to detect and quantify guanfacine in urine","volume":"50","author":"Wolf","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"R10-20261114","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2174\/1573412918666220614144710","article-title":"Development and validation of a high-performance liquid chromatography-mass spectroscopy assay for the bioequivalence study of guanfacine extended release (GXR) tablet in human plasma","volume":"18","author":"Zou","year":"2022","journal-title":"Curr Pharm Anal"},{"key":"R11-20261114","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cpt.802","article-title":"The universally unrecognized assumption in predicting drug clearance and organ extraction ratio","volume":"103","author":"Benet","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"R12-20261114","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/10600280221126438","article-title":"Impact of extracorporeal membrane oxygenation on the pharmacokinetics and pharmacodynamics of critical care therapies: a narrative review","volume":"57","author":"Patel","year":"2023","journal-title":"Ann Pharmacother"},{"key":"R13-20261114","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1053\/j.jvca.2025.05.021","article-title":"Extracorporeal membrane oxygenation in the awake or extubated patient","volume":"39","author":"Cuttone","year":"2025","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R14-20261114","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/10600280211010751","article-title":"Approach to sedation and analgesia in COVID-19 patients on venovenous extracorporeal membrane oxygenation","volume":"56","author":"Dreucean","year":"2022","journal-title":"Ann Pharmacother"},{"key":"R15-20261114","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10047-025-01494-y","article-title":"Sedation management and processed EEG-based solutions during venovenous extracorporeal membrane oxygenation: a narrative review of key challenges and potential benefits","volume":"28","author":"Szentgyorgyi","year":"2025","journal-title":"J Artif Organs"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:00:22Z","timestamp":1794664822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001447","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"2025-10-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}